Abstract P4-14-13: Pertuzumab (P) use in first-line HER2-positive metastatic breast cancer (mBC) in US community oncology practices: Treatment patterns and outcomes
Year: 2016
Type: conference-abstract
Source: Cancer Research
Institution: Genentech
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: pertuzumab, HER2-positive metastatic breast cancer, first-line therapy, trastuzumab, docetaxel, treatment patterns, adverse events, progression-free survival, community oncology practice, real-world outcomes, peripheral neuropathy, neutropenia, rash, diarrhea, fatigue, hormone receptor-positive breast cancer, breast cancer recurrence, de novo metastatic breast cancer
Open Access status: closed
OpenAlex ID: W2395037535
